마이너 카나비노이드 시장 : 제품별, 용도별 - 세계 예측(2024-2030년)

[193 Pages Report] The Minor Cannabinoids Market size was estimated at USD 17.63 billion in 2023 and expected to reach USD 18.79 billion in 2024, at a CAGR 7.95% to reach USD 30.13 billion by 2030.

Global Minor Cannabinoids Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Minor Cannabinoids Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Minor Cannabinoids Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Minor Cannabinoids Market, highlighting leading vendors and their innovative profiles. These include Fresh Bros Hemp Company, GenCanna, Global Cannabinoids, Laurelcrest, Mile High labs International, Pacific Roots, LLC, Rhizo Sciences, Sanobiotec, and Zero Point Extraction, LLC.

Market Segmentation & Coverage

This research report categorizes the Minor Cannabinoids Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Products
  • Cannabichromene
  • Cannabigerol
  • Cannabigerolic Acid
  • Cannabinol
  • Tetrahydrocannabivarin
• Application
  • Cancer
  • Inflammation
  • Neurological Disorders
  • Pain Management
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Minor Cannabinoids Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Minor Cannabinoids Market?

3. What are the technology trends and regulatory frameworks in the Minor Cannabinoids Market?

4. What is the market share of the leading vendors in the Minor Cannabinoids Market?

5. Which modes and strategic moves are suitable for entering the Minor Cannabinoids Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Minor Cannabinoids Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Medical benefits of minor cannabinoids
    • 5.1.1.2. Increasing legalization of cannabinoids
    • 5.1.1.3. Introduction of new minor-cannabinoid food & beverage products
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of minor cannabinoids
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing R&D of minor cannabinoids
    • 5.1.3.2. Funding and investments for better product commercialization
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulations regarding minor cannabinoids
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Minor Cannabinoids Market, by Products

• 6.1. Introduction
• 6.2. Cannabichromene
• 6.3. Cannabigerol
• 6.4. Cannabigerolic Acid
• 6.5. Cannabinol
• 6.6. Tetrahydrocannabivarin

7. Minor Cannabinoids Market, by Application

• 7.1. Introduction
• 7.2. Cancer
• 7.3. Inflammation
• 7.4. Neurological Disorders
• 7.5. Pain Management

8. Americas Minor Cannabinoids Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Minor Cannabinoids Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Minor Cannabinoids Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

• 12.1. Key Company Profiles
  • 12.1.1. Fresh Bros Hemp Company
  • 12.1.2. GenCanna
  • 12.1.3. Global Cannabinoids
  • 12.1.4. Laurelcrest
  • 12.1.5. Mile High labs International
  • 12.1.6. Pacific Roots, LLC
  • 12.1.7. Rhizo Sciences
  • 12.1.8. Sanobiotec
  • 12.1.9. Zero Point Extraction, LLC
• 12.2. Key Product Portfolio

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing